XL647—A Multitargeted Tyrosine Kinase Inhibitor: Results of a Phase II Study in Subjects with Non-small Cell Lung Cancer Who Have Progressed after Responding to Treatment with Either Gefitinib or Erlotinib
Pietanza, M. Catherine, Lynch, Thomas James, Lara, Primo N., Cho, John, Yanagihara, Ronald H., Vrindavanam, Nandagopal, Chowhan, Naveed Mahfooz, Gadgeel, Shirish M., Pennell, Nathan A., Funke, Roel, MVolume:
7
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/JTO.0b013e31822eebf9
Date:
January, 2012
File:
PDF, 776 KB
english, 2012